Literature DB >> 2317764

Fine needle aspiration cytology of chondroblastoma of bone.

C V Fanning1, N S Sneige, C H Carrasco, A G Ayala, J A Murray, A K Raymond.   

Abstract

Between 1979 and 1987 12 patients with chondroblastoma underwent fine needle aspiration (FNA). There were eight female and four male patients (age range, 11-35 years) with lesions of the proximal humerus (three cases), distal femur (two cases), proximal tibia (two cases), proximal femur, distal tibia, talus, navicular bone, and fifth metacarpal (one case each). The radiologic features of the tumors were not entirely typical of chondroblastoma in the majority of patients. The aspirate was diagnosed as chondroblastoma in seven cases, was considered strongly suggestive of chondroblastoma in one case, was found to be diagnosable as chondroblastoma on review in one case, and was nondiagnostic in two cases. The remaining case, which showed giant cell tumor-like areas in addition to typical chondroblastoma on histologic sections from the curettage, was interpreted as giant cell tumor on FNA. There was no case in which an aspirate was erroneously diagnosed as chondroblastoma. On FNA, chondroblastoma had three dominant cytologic components: neoplastic mononuclear cells (chondroblasts), multinucleated osteoclast-like giant cells, and chondroid matrix fragments. The chondroblasts tended to lie individually in smears creating a pebbled appearance. They most commonly had round to oval nuclei with fine, evenly distributed chromatin and distinct longitudinal grooves, but indented, lobulated, and pyknotic nuclei were also observed. Their cytoplasm was dense and opaque with rounded well-defined borders. Multinucleated osteoclast-like giant cells were randomly admixed and were indistinguishable from those seen in other bone neoplasms. Chondroid matrix stained magenta with the Diff-Quik stain and green to violet with Papanicolaou. The cytologic features of the chondroblasts are the diagnostic hallmark of chondroblastoma and may allow FNA to become a valuable preoperative technique in the management of these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2317764     DOI: 10.1002/1097-0142(19900415)65:8<1847::aid-cncr2820650831>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Receptor activator of NF-kappaB ligand (RANKL) is expressed in chondroblastoma: possible involvement in osteoclastic giant cell recruitment.

Authors:  L Huang; Y Y Cheng; L T C Chow; M H Zheng; S M Kumta
Journal:  Mol Pathol       Date:  2003-04

2.  Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.

Authors:  Inga-Marie Schaefer; Jonathan A Fletcher; G Petur Nielsen; Angela R Shih; Marco L Ferrone; Jason L Hornick; Xiaohua Qian
Journal:  Cancer Cytopathol       Date:  2018-05-14       Impact factor: 5.284

3.  Chondroblastoma of the Clivus: Case Report and Review.

Authors:  Jonathan Liu; Arjang Ahmadpour; Arnaud F Bewley; Mirna Lechpammer; Matthew Bobinski; Kiarash Shahlaie
Journal:  J Neurol Surg Rep       Date:  2015-10-09

4.  Fine needle aspiration cytology of chondroblastoma: A report of two cases with brief review of pitfalls.

Authors:  Amita Krishnappa; S N Shobha; S Vijay Shankar; Sushma Aradhya
Journal:  J Cytol       Date:  2016 Jan-Mar       Impact factor: 1.000

5.  Sacral chondroblastoma - a rare location, a rare pathology: A case report and review of literature.

Authors:  Bo-Wen Zheng; Hua-Qing Niu; Xiao-Bin Wang; Jing Li
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.